Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to mi…
$452.80-3.36%
报价 2026-11-06
市值
$159.96B
EV
$166.7B
PE (TTM)
59.4x
预期 PE (FY2026)
40.3x
52 周区间距高点 -23.6%
$332.02$592.85
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-07未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 1.2x | 11.13 → 12.48（1.1x） | 36.3 |
| FY+32028-12 | 1.3x | 11.13 → 14.03（1.3x） | 32.3 |
毛利率 66% · TTM 收入 $11578M · 基数 EPS 11.13（调整后）
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| ISRGIntuitive Surgical, Inc. | $159.96B | -3.4% | +17.5% | 68.4% | 59.4x | 46.0x | 64.2x | |
| BDXBecton, Dickinson and Company | $57.71B | -0.8% | +2.4% | 45.8% | 25.3x | 14.7x | 17.3x | |
| RMDResMed Inc. | $33.1B | -1.7% | +7.6% | 61% | 22.5x | 15.9x | 18.6x | |
| WSTWest Pharmaceutical Services, Inc. | $27.85B | +1.9% | +11.6% | 39.7% | 45.5x | 29.2x | 62.7x | |
| BAXBaxter International Inc. | $13.34B | +0.5% | +5.8% | 33.4% | – | 25.2x | 13.3x | |
| COOThe Cooper Companies, Inc. | $11.86B | -1.8% | +4.0% | 62.4% | 19.1x | 14.6x | 16.1x | |
| RGENRepligen Corporation | $11.09B | +3.0% | +15.8% | 53.1% | 233.1x | 56.2x | 87.9x | |
| TFXTeleflex Incorporated | $6.39B | -0.8% | -30.7% | 53.3% | – | 63.6x | 26.1x | |
| MMSIMerit Medical Systems, Inc. | $5.23B | -2.7% | +7.1% | 48.7% | 31.5x | 13.5x | 20.7x | |
| 同行中位数 | – | – | +6.5% | 50.9% | 28.4x | 20.5x | 19.6x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-09-30 Q3 2026 | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.05B | $2.89B | $2.77B | $2.87B | $2.51B | $2.44B | $2.25B | $2.41B |
| Gross Margin | 68.4% | 67.8% | 66.1% | 66.4% | 66.4% | 66.3% | 64.7% | 68% |
| Operating Margin | 19.4% | 33.6% | 30.9% | 30.2% | 30.3% | 30.5% | 25.7% | 30.4% |
| Net Income | $522.8M | $818.1M | $821.5M | $794.8M | $704.4M | $658.4M | $698.4M | $685.7M |
| Diluted EPS | 1.49 | 2.35 | 2.28 | 2.21 | 1.95 | 1.81 | 1.92 | 1.88 |
| Operating Cash Flow | $1.22B | $1.06B | $911.9M | $892.5M | $841M | $715.4M | $581.6M | $822.6M |